Pyridazinone macrocycles as IRAK inhibitors and uses thereof
US10517872B2 · kind B2 · utility
1Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2017 |
| Grant date | Dec 31, 2019 |
| Priority date | — |
| Expiry date | Mar 6, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.